AcQMap® Global Registry of Procedural and Long-term Clinical Outcomes (AcQMap Registry)

NCT03893331 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 479

Last updated 2023-11-13

No results posted yet for this study

Summary

AcQMap Registry is an observational study

Conditions

  • Ablation of Arrhythmia's

Interventions

DEVICE

AcQMap System

To evaluate procedural and long-term outcomes when using the diagnostic AcQMap System as an imaging and mapping system for ablation of arrhythmias in accordance with the Instructions for Use (IFU).

Sponsors & Collaborators

  • Acutus Medical

    lead INDUSTRY

Principal Investigators

  • Simon James, MD · James Cook University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-13
Primary Completion
2023-11-08
Completion
2023-11-08
FDA Device
Yes

Countries

  • France
  • Germany
  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03893331 on ClinicalTrials.gov